Shopping Cart
Remove All
Your shopping cart is currently empty
HK-2-IN-1 is an inhibitor of Hexokinase 2 (HK-2). It exhibits non-activation effects on human recombinant HK-2 enzyme. HK-2-IN-1 possesses antitumor activity, impacting immune cells within the tumor microenvironment. It has immunomodulatory properties and is applicable in research on cancers such as colon cancer, liver cancer, and breast cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | HK-2-IN-1 is an inhibitor of Hexokinase 2 (HK-2). It exhibits non-activation effects on human recombinant HK-2 enzyme. HK-2-IN-1 possesses antitumor activity, impacting immune cells within the tumor microenvironment. It has immunomodulatory properties and is applicable in research on cancers such as colon cancer, liver cancer, and breast cancer. |
| In vitro | HK-2-IN-1 (Compound 20) demonstrates cytotoxic effects against HCT-116, HepG2, 4T1, and MCF7 cells after 48 hours at concentrations between 50-1000 μM, with IC50 values of 22.04 μM, 21.19 μM, 54.69 μM, and 192.3 μM, respectively, while exhibiting no cytotoxicity towards healthy fibroblasts. |
| In vivo | The compound HK-2-IN-1 (Compound 20), administered at a dosage of 5 mg/kg intraperitoneally once a day for 4 weeks, inhibits tumor growth and metastasis in mice with 4T1 tumors. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.